The antioxidative property of melatonin against brain ischemia (Q38816026)

6 September 2017

title

The antioxidative property of melatonin against brain ischemia (English)

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Irene Paterniti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Emanuela Esposito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

24 April 2016

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

841-848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Protective effect of nimodipine against ischemic neuronal damage in rat hippocampus without changing postischemic cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Vinpocetine prevents ischemic cell damage in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Dihydrolipoate reduces neuronal injury after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Ischemia-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The changing landscape of ischaemic brain injury mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Role of calcium in neuronal cell injury: which subcellular compartment is involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Reactive oxygen radicals in signaling and damage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Cerebral ischemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Nitric oxide synthase: Aspects concerning structure and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Glutamate, nitric oxide and cell-cell signalling in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Nitric oxide in excitable tissues: physiological roles and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Effect of melatonin on cell growth, metabolic activity, and cell cycle distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The chemistry of melatonin's interaction with reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Free Radical-Mediated Molecular Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin, mitochondria, and cellular bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Functional MT1 and MT2 melatonin receptors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

On the role of melatonin in skin physiology and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Physiological and metabolic functions of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

A Review of the Multiple Actions of Melatonin on the Immune System

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Nuclear melatonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The role of melatonin in the cells of the innate immunity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin mitigates mitochondrial malfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The role of melatonin on gastric mucosal cell proliferation and telomerase activity in ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin and cell death: differential actions on apoptosis in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Effects of melatonin on the nitric oxide system and protein nitration in the hypobaric hypoxic rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Potential therapeutic effect of antioxidant therapy in shock and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

N-acetylserotonin activates TrkB receptor in a circadian rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Antiinflammatory activity of melatonin in central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin Counteracts at a Transcriptional Level the Inflammatory and Apoptotic Response Secondary to Ischemic Brain Injury Induced by Middle Cerebral Artery Blockade in Aging Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

The use of melatonin in hypoxic-ischemic brain damage: an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1182020

10.1080/14737175.2016.1182020

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108742%20AND%20SRC:MED&resulttype=core&format=json